Parainfluenza virus infections therapy (China Grand Pharmaceutical and Healthcare/Griffith University)

N/A

Report date: 2024/10/30 10:29:08
NME

Base Information

Drug NameParainfluenza virus infections therapy (China Grand Pharmaceutical and Healthcare/Griffith University)
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsParamyxoviridae Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsParamyxoviridae Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A